References
Gullick WJ: Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991, 47:87–98.
Yamanaka Y: The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer. Nippon Ika Daigaku Zasshi 1992, 59:51–61.
Itakura Y, Sasano H, Shiga C, et al.: Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994, 74:795–804.
Yang XD, Jia XC, Corvalan JR, et al.: Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy. Cancer Res 1999, 59:1236–1243.
Sargent ER, Gomella LG, Belldegrun A, et al.: Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. J Urol 1989, 142:1364–1368.
Weidner U, Peter S, Strohmeyer T, et al.: Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. Cancer Res 1990, 50:4504–4509.
Yoshida K, Tosaka A, Takeuchi S, Kobayashi N: Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 1994, 73:1913–1918.
Mendez MJ, Green LL, Corvalan JR, et al.: Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 1997, 15:146–156.
Rights and permissions
About this article
Cite this article
Kim, H.L., Pantuck, A.J., Zomorodian, N. et al. Monoclonal antibodies for the treatment of advanced cancer. Curr Urol Rep 4, 11–12 (2003). https://doi.org/10.1007/s11934-003-0051-x
Issue Date:
DOI: https://doi.org/10.1007/s11934-003-0051-x